Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Atropine injection
Atropine miniject
Avatrombopag	TA626 - Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
Avelumab (Bavencio®)	TA517 - Avelumab for treating metastatic Merkel cell carcinoma TA644 - Avelumab with axitinib for untreated advanced renal cell carcinoma
Axitinib	TA218 - Myelodysplastic syndromes - azacitidine	National CDF list
Azathioprine injection		For hospital use only
Azathioprine suspension
Azathioprine tablets
Baclofen intrathecal injection		Hospital only
Balanced slat solution		Theatre use

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.